Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03197324 · ClinicalTrials.gov registry record · Phase 1
Bexagliflozin Drug/Drug Interaction Study With Digoxin
A Phase 1 study, sponsored by Theracos.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
NCT03197324 is a Phase 1 study that has completed, run by Theracos. The registered enrollment target is 20 participants.
The verdict
NCT03197324, a Phase 1 study, has completed, sponsored by Theracos.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the drug-drug interaction in your body when given the study drug, bexagliflozin, with the heart failure medication digoxin. The study will evaluate whether bexagliflozin effects the amount of digoxin in your blood and how safe the study drug is and how well the study drug is tolerated when taken with digoxin.
Interventions
- DRUG Digoxin
- DRUG Bexagliflozin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2017-07-24 |
| Est. Completion | 2017-09-17 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03197324
The ClinicalTrials.gov registry entry for NCT03197324 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Theracos, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Digoxin is the first listed.
NCT03197324 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03197324 about?
NCT03197324 is a clinical study titled "Bexagliflozin Drug/Drug Interaction Study With Digoxin". The purpose of this study is to examine the drug-drug interaction in your body when given the study drug, bexagliflozin, with the heart failure medication digoxin. The study will evaluate whether bexagliflozin effects the amount of digoxin in your blood and how safe the study drug is and how well th...
What is the current status of trial NCT03197324?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2017-07-24. Estimated completion is 2017-09-17.
What interventions are being tested in trial NCT03197324?
The interventions under investigation include: Digoxin (DRUG), Bexagliflozin (DRUG).
Who is sponsoring clinical trial NCT03197324?
This trial is sponsored by Theracos, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.